State of Wisconsin Investment Board
AXSM icon

State of Wisconsin Investment Board’s Axsome Therapeutics AXSM Stock Holding History

State of Wisconsin Investment Board’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.83M Buy
40,381
+13,778
+52% +$2.38M 0.02% 859
2025
Q4 		$4.86M Sell
26,603
-3,722
-12% -$520K 0.01% 1018
2025
Q3 		$3.68M Buy
30,325
+4,478
+17% +$504K 0.01% 1074
2025
Q2 		$2.7M Sell
25,847
-4,933
-16% -$522K 0.01% 1161
2025
Q1 		$3.59M Buy
30,780
+3,401
+12% +$387K 0.01% 1038
2024
Q4 		$2.32M Buy
27,379
+2,021
+8% +$186K 0.01% 1227
2024
Q3 		$2.28M Buy
25,358
+2,000
+9% +$175K 0.01% 1259
2024
Q2 		$1.88M Buy
23,358
+1,017
+5% +$75.3K 0.01% 1313
2024
Q1 		$1.78M Sell
22,341
-2,877
-11% -$241K ﹤0.01% 1284
2023
Q4 		$2.01M Sell
25,218
-3,939
-14% -$263K 0.01% 1236
2023
Q3 		$2.04M Sell
29,157
-9,088
-24% -$679K 0.01% 1250
2023
Q2 		$2.75M Buy
38,245
+8,649
+29% +$638K 0.01% 1207
2023
Q1 		$1.83M Sell
29,596
-672
-2% -$44.1K 0.01% 1333
2022
Q4 		$2.33M Buy
30,268
+1,229
+4% +$73.5K 0.01% 1274
2022
Q3 		$1.3M Buy
29,039
+1,821
+7% +$91K ﹤0.01% 1448
2022
Q2 		$1.04M Sell
27,218
-12,282
-31% -$388K ﹤0.01% 1611
2022
Q1 		$1.64M Hold
39,500
– – ﹤0.01% 1546
2021
Q4 		$1.49M Hold
39,500
– – ﹤0.01% 1343
2021
Q3 		$1.3M Hold
39,500
– – ﹤0.01% 1375
2021
Q2 		$2.67M Hold
39,500
– – 0.01% 1218
2021
Q1 		$2.24M Sell
39,500
-2,500
-6% -$176K ﹤0.01% 1220
2020
Q4 		$3.42M Sell
42,000
-7,000
-14% -$523K 0.01% 1097
2020
Q3 		$3.49M Buy
49,000
+3,500
+8% +$273K 0.01% 1045
2020
Q2 		$3.74M Buy
45,500
+3,800
+9% +$292K 0.01% 969
2020
Q1 		$2.45M Buy
41,700
+5,200
+14% +$424K 0.01% 1015
2019
Q4 		$3.77M Hold
36,500
– – 0.01% 1013
2019
Q3 		$739K Buy
+36,500
New +$938K ﹤0.01% 1209

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State of Wisconsin Investment Board's AXSM Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Axsome Therapeutics (AXSM) stake by 52% in Q1 2026, buying an estimated $2.38M and bringing the position to 40,381 shares worth $6.83M. The position accounts for 0.02% of the portfolio, ranked #859.

State of Wisconsin Investment Board first reported a position in AXSM in Q3 2019 and has held it in 27 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • State of Wisconsin Investment Board held 40,381 shares of Axsome Therapeutics worth $6.83M as of Q1 2026.
  • State of Wisconsin Investment Board bought 13,778 Axsome Therapeutics shares in Q1 2026, an estimated $2.38M.
  • Axsome Therapeutics made up 0.02% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #859 holding.
  • State of Wisconsin Investment Board first reported a position in Axsome Therapeutics in Q3 2019 and has held it in 27 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.